InvestorsHub Logo
Followers 24
Posts 3808
Boards Moderated 0
Alias Born 02/04/2013

Re: geocappy1 post# 188273

Friday, 08/29/2014 1:26:39 PM

Friday, August 29, 2014 1:26:39 PM

Post# of 346360
Geo: Here is a PR from a company with an enrollment milestone and the one statement by the CEO is so clear. I will try to find some more references.

"We are excited to have reached the halfway point in the enrollment of our Squalamine Eye Drop study," said Dr. Irach B. Taraporewala, CEO of Ohr. "This milestone sets the stage for the planned interim analysis once the 60 patients complete the nine month treatment protocol, and we expect the data to be available in the second quarter of 2014."

http://www.ohrpharmaceutical.com/media-center/press-releases/detail/16/ohr-pharmaceutical-achieves-50-enrollment-milestone-in
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News